BioCentury
ARTICLE | Clinical News

EpiStem, Rottapharm S.p.A. preclinical data

September 8, 2008 7:00 AM UTC

In vitro studies of CR 3294, an inducible nitric oxide synthase ( iNOS) and matrix metalloproteinase (MMP) co-inhibitor, showed that it protected small intestinal crypts from cytotoxic insult of comm...